Beta Health Care Service No 2

Enzo Biochem Releases Clinical Trial Results of EGS21 for Treatment of Non-Alcoholic Steatohepatitis.(Clinical report)
Health & Beauty Close-Up; 11/4/2009; 1122 words; ...administered beta glucosylceramide...NKT cells. No treatment...steatosis. No significant...NASH affects 2 to 5 percent...currently there is no effective medical...licensing of health care products and...providing diagnostic services to the medical...

Study data from Kyoto University provide new insights into violent behavior.
Biotech Week; 11/4/2009; 905 words; ...There have been no studies of the...physical and mental health of caregivers...providing home-care services in Japan. Degree...years, and 29.2% were men...Caregivers (beta-coefficient...95% CI: 2.92 to 8...Medicine, Mental Health, Psychiatry...

Distracted Driving is the Webster's New World(R) 2009 Word of the Year.
PR Newswire; 11/2/2009; 1234 words; ...J., Nov. 2 /PRNewswire...connection (a beta definition...before medical service is provided...enabling the health care provider to...on national health care and a number...approximately 2 million such...language as no other dictionary...

Enzo Biochem Reports on Favorable Clinical Trial of EGS21 for Treatment of Non-Alcoholic Steatohepatitis.(Clinical report)
Business Wire; 11/2/2009; 1529 words; ...administered beta glucosylceramide...NKT cells. No treatment...steatosis. No significant...NASH affects 2 to 5 percent...currently there is no effective medical...of innovative health care products and...providing diagnostic services to the medical...

Aberdeen charges too much.
Investors Chronicle - magazine and web content; 10/8/2009; 1069 words; ...the odds for no clear benefit...expense ratio] of 2.13 per cent...7.37%| |No OF HOLDINGS...EXPENSE RATIO|2.13%*| |3-YEAR BETA|0.91...Consumer Services|20.2...Utilities|7| |Health Care|5.9| |Industrials...